Royalty Pharma Lifts Elan Bid to $13.00 a Share Plus CVR

Royalty Pharma raised its offer for Elan Corp Plc to $13.00 a share plus a contingent value right of as much as $2.50 a share, the company said today.

The offer, previously at $12.50 per share, potentially values each Elan share at up to $15.50 if additional CVR payment events occur, according to the statement.

Before it's here, it's on the Bloomberg Terminal.